1Policy, Critical Nursing, Drug Discovery; Medicinal Toxicology & QC, At : Sri Radha Krishna Raas Mandir, Kedar Gouri Main Road, Bhubaneswar–751002, Odisha, India, ORCID : https://orcid.org/0000-0002-0496-6481
2Professor, Department of Obstetrics and Gynaecology, IMS and SUM Hospital, ORCID: https://orcid.org/0000-0002-3801-7356
3Associate Professor, Department of Biology, University of Mohaghegh, Ardabili, Iran, ORCID: https://orcid.org/0000-0003-3314-2948
4Department of Botany, Centurion University of Technology and Management, Bhubaneswar, Odisha, India, ORCID: https://orcid.org/0000-0001-7747-0877
5School of Basic Medical Sciences, Faculty of Medicine, Kampus Perubatan, Universiti Sultan Zainal Abidin, 20400, Kuala Terengganu, Malaysia, ORCID : https://orcid.org/0000-0003-4753-0423
6Microbiologist, Islamic Azad University, Tabriz branch, Iran, ORCID : https://orcid.org/0009-0008-5680-8195
*Corresponding Author E-mail: raousm@unisza.edu.my
Online Published on 15 May, 2025.
Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide, with rising incidence and significant challenges, including high recurrence rates, local and distant metastasis, and severe lifestyle disruptions. Despite the availability of treatment options, including chemotherapy, the need for cold-chain-dependent drugs, and the associated toxic side effects pose substantial barriers to effective care, particularly in rural and remote areas. Family Physicians (FPs), who are well-equipped with local support teams, medical expertise, and drug storage facilities, are uniquely positioned to assist in CRC management. However, due to a widespread misconception that legal frameworks do not permit their involvement, they largely refrain from treating cancer patients. Notably, in India—the world’s largest democracy—laws do allow FPs to play a more active role in oncology care, yet this remains largely unknown and underutilized. FPs also possess deep knowledge of Functional Foods (FFs), which are abundant in tropical and equatorial regions and have demonstrated potential in mitigating chemotherapy side effects, enhancing patient recovery, and improving overall well-being. Integrating FFs into CRC management under the supervision of FPs could offer a holistic, patient-centered approach that benefits all stakeholders—patients, healthcare providers, and the pharmaceutical industry. This paper explores the potential role of FPs in CRC care, the integration of FFs in treatment regimens, and the medico-legal considerations surrounding this paradigm shift. By leveraging the expertise and accessibility of FPs, CRC management can be made more comprehensive, ensuring better patient outcomes, economic benefits, and an expanded healthcare market that prioritizes family welfare and prolonged survival.
Colo-Rectal Cancer, Family Physician, Functional Foods, Indian NMC Act 2019 (32)